GlassScriptPhysician profile
Margaret A Kessler
NPI 1326240946
$11,677.98
in general payments reported to CMS, 2019-2025
38 companies · $2,728 in 2025
The $2,728 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,145 · 2020: $745 · 2021: $915 · 2022: $1,586 · 2023: $2,043 · 2024: $2,517 · 2025: $2,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,170 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,170.46 |
| Education | $117.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,694.56 | 2019-2025 | |
| Amgen INC. | $987.55 | 2019-2025 | Otezla, Enbrel, Otezla |
| Sun Pharmaceutical Industries INC. | $757.35 | 2019-2025 | Blu-U, Winlevi, Ilumya |
| Incyte Corporation | $608.80 | 2021-2025 | Opzelura |
| Genzyme Corporation | $570.14 | 2020-2025 | |
| Pfizer INC. | $563.47 | 2019-2025 | |
| Leo Pharma INC. | $543.50 | 2021-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $529.64 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $498.56 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $482.40 | 2019-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $439.55 | 2023-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $393.10 | 2023-2025 | Nemluvio |
| Janssen Biotech, INC. | $374.65 | 2019-2025 | Tremfya, Stelara, Simponi |
| Ucb, INC. | $365.08 | 2019-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $314.02 | 2023-2025 | Zoryve |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.